Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02725489
Title Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mary Crowley Medical Research Center

ovarian cancer

cervical cancer

endometrial cancer

breast cancer

fallopian tube cancer

uterine cancer

peritoneum cancer


Durvalumab + FANG vaccine

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.